Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 1
2005 5
2006 5
2007 1
2008 1
2009 1
2010 4
2011 5
2012 4
2013 1
2014 2
2015 1
2016 3
2017 2
2018 3
2019 2
2020 2
2021 5
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
The role of extracellular DNA (exDNA) in cellular processes.
Fernández-Domínguez IJ, Manzo-Merino J, Taja-Chayeb L, Dueñas-González A, Pérez-Cárdenas E, Trejo-Becerril C. Fernández-Domínguez IJ, et al. Among authors: taja chayeb l. Cancer Biol Ther. 2021 Apr 3;22(4):267-278. doi: 10.1080/15384047.2021.1890319. Epub 2021 Apr 16. Cancer Biol Ther. 2021. PMID: 33858306 Free PMC article. Review.
Progress in Metabolic Studies of Gastric Cancer and Therapeutic Implications.
Romo-Perez A, Dominguez-Gomez G, Chavez-Blanco A, Taja-Chayeb L, Gonzalez-Fierro A, Diaz-Romero C, Lopez-Basave HN, Duenas-Gonzalez A. Romo-Perez A, et al. Among authors: taja chayeb l. Curr Cancer Drug Targets. 2022;22(9):703-716. doi: 10.2174/1568009622666220413083534. Curr Cancer Drug Targets. 2022. PMID: 35422220 Review.
Viral inhibitors of NKG2D ligands for tumor surveillance.
Chávez-Blanco A, Chacón-Salinas R, Dominguez-Gomez G, Gonzalez-Fierro A, Perez-Cardenas E, Taja-Chayeb L, Trejo-Becerril C, Duenas-Gonzalez A. Chávez-Blanco A, et al. Among authors: taja chayeb l. Expert Opin Ther Targets. 2016 Nov;20(11):1375-1387. doi: 10.1080/14728222.2016.1202928. Epub 2016 Jun 29. Expert Opin Ther Targets. 2016. PMID: 27322108 Review.
Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy.
Schcolnik-Cabrera A, Chávez-Blanco A, Domínguez-Gómez G, Taja-Chayeb L, Morales-Barcenas R, Trejo-Becerril C, Perez-Cardenas E, Gonzalez-Fierro A, Dueñas-González A. Schcolnik-Cabrera A, et al. Among authors: taja chayeb l. Expert Opin Investig Drugs. 2018 May;27(5):475-489. doi: 10.1080/13543784.2018.1471132. Epub 2018 May 10. Expert Opin Investig Drugs. 2018. PMID: 29723075 Review.
Ribavirin as a tri-targeted antitumor repositioned drug.
De la Cruz-Hernandez E, Medina-Franco JL, Trujillo J, Chavez-Blanco A, Dominguez-Gomez G, Perez-Cardenas E, Gonzalez-Fierro A, Taja-Chayeb L, Dueñas-Gonzalez A. De la Cruz-Hernandez E, et al. Among authors: taja chayeb l. Oncol Rep. 2015 May;33(5):2384-92. doi: 10.3892/or.2015.3816. Epub 2015 Feb 25. Oncol Rep. 2015. PMID: 25738706
Growth inhibition and transcriptional effects of ribavirin in lymphoma.
Dominguez-Gomez G, Cortez-Pedroza D, Chavez-Blanco A, Taja-Chayeb L, Hidalgo-Miranda A, Cedro-Tanda A, Beltran-Anaya F, Diaz-Chavez J, Schcolnik-Cabrera A, Gonzalez-Fierro A, Dueñas-Gonzalez A. Dominguez-Gomez G, et al. Among authors: taja chayeb l. Oncol Rep. 2019 Sep;42(3):1248-1256. doi: 10.3892/or.2019.7240. Epub 2019 Jul 17. Oncol Rep. 2019. PMID: 31322273
48 results